news
World news
Europe
Europe warns: Britain too quickly approved Pfizer's corona vaccine
The European Medicines Agency has said further findings and tests are needed and will make the decision on December 29, while the UK already plans to start vaccinating next week.
"It is better to take the time and ensure quality, efficiency and safety," said a German legislator.
The kingdom insists there were no shortcuts
Tags
Vaccine for corona
Corona virus
UK
News agencies
Wednesday, 02 December 2020, 13:35
Share on Facebook
Share on WhatsApp
Share on general
Share on general
Share on Twitter
Share on Email
0 comments
Head of Public Health Services: "This is the beginning of a wave ...
Gaza warns: Health system on the verge of collapse due to immigration ...
Grotto: If the malls pilot succeeds, we will expand it, subject to ...
Shooting at a bank branch in Marar: suspect killed, young woman moderately injured ...
Netanyahu at the Ben Gurion Memorial Ceremony: It is forbidden to return to the agreement ...
Violence incident in Jerusalem, two family members were seriously injured ...
Singer Jonathan Margie performs at a nursery in Tel Aviv
Edelstein: The Cabinet made the right decision - to open ...
A car collided with the gates of Merkel's office in Berlin, there were no ...
The Keren Or therapeutic farm is in danger of closing due to a crisis ...
Ganz: Blue and white will vote tomorrow in favor of the proposal to dissolve the Knesset 1 ...
Biden: The corona destroyed the United States, causing a loss ...
In the video: The British Minister of Health expresses satisfaction with the approval for the use of the Pfizer vaccine (Photo: Reuters, edited by Tal Reznik)
The European Medicines Control Agency and MEPs have warned of hasty approvals for Corona vaccines, after the UK issued an emergency approval for the vaccine developed by Pfizer and BioNTech.
The move was seen as a political achievement by the government of Boris Johnson, who faced criticism of his treatment of the corona plague.
The approval was given in an emergency and quick procedure, but UK authorities claim they have met the required standards.
The European Medicines Agency, which is responsible for approving the vaccines for the virus in the EU countries, said that a longer procedure should be followed than that of the UK, due to the need for further findings and tests.
The agency said yesterday that as part of the mechanism it operated, the decision on whether to approve Pfizer's vaccine would be made on December 29.
The UK is the first country in the world to approve Pfizer's vaccine for use, even before the United States in the United States, the US Food and Drug Administration (FDA) is expected to discuss the company's request for an emergency permit in about a week.
More on Walla!
NEWS
Israel will pay tens of millions of dollars for the Russian vaccine - and will not use it
To the full article
Good news for him and for the UK.
Johnson at corona vaccine plant (Photo: Reuters)
Several European lawmakers have criticized Britain's decision.
"I see this as a problematic decision and recommend that the EU member states not repeat this procedure," said Peter Lisa, a lawmaker from the center-right bloc in the European Parliament, a member of German Chancellor Angela Merkel's ruling party.
He said it was better to wait a few more weeks of testing as the European Medicines Agency does.
Under EU law, the agency must give approval for Pfizer's vaccine, but companies in the bloc can use an emergency regulation to distribute vaccine in their territories for temporary use.
Britain is still subject to EU law until the transition period ends in early 2021.
"There is a clear global race to get the vaccine on the market as soon as possible," said Timo Vulcan, a European legislator from the Socialist bloc, the second largest in parliament after the center-right bloc.
"However, I believe it is best to take the time and ensure quality, efficiency and safety in line with EU standards."
UK regulators insist they have not taken any shortcuts.
They are currently considering approval for another vaccine, developed by AstraZenica and the University of Oxford in the UK.
"The way the MHRA works is in line with all international standards," said John Rine of the UK Drugs Regulatory Body.
She said the Brexit did not lead to an accelerated emergency clearance.
A breakthrough in the fight against the plague.
Pfizer's vaccine (Photo: Reuters)
It is the vaccine that is developed at record speed - only ten months - compared to the decade usually required to complete all the stages.
The UK's Chief Health Officer, Chris Witty, said only in the spring would the vaccine be available to any at-risk population wanting to be vaccinated.
The UK Vaccine Commission will determine that the first to receive the vaccines will be residents of nursing homes, medical and social staff and people particularly vulnerable to the virus will be first in line.
Johnson said this is "fantastic" news that will lead to a recovery in the economy.
"The vaccine will start to be available across the UK starting next week," tweeted the conservative prime minister, who was hospitalized in critical condition earlier this year after contracting the virus.
Britain is one of the countries hardest hit by the epidemic, with more than 59,000 dead and 1.64 million diagnosed.
His treatment of the epidemic has received much criticism, but the start of vaccines could help him politically, and for the UK economy, whose negotiations with the EU on post-Brexit economic relations.
"It's the protection of vaccines that will allow us to eventually get back into our lives and move the economy back," Johnson added.
Challenging distribution operation
Health Minister Matt Hancock told the Sky network that in about a week, the first vaccinators are expected to receive ready-to-use doses.
"From the beginning of next week, we will start a program to vaccinate people against the Cubid-19 virus here in this country, this is great news," he said.
He added that hospitals are poised to quickly set up vaccination centers in the country, but admitted that their distribution would be challenging because Pfizer's vaccine must be kept at -70 degrees, a temperature typical of the Arctic winter.
At standard freezer temperatures, vaccines can last up to five days, and in thermal shipping boxes up to 15 days.
Johnson said last month that the UK had ordered 40 million doses of Pfizer vaccines, an amount sufficient for at least a third of the UK population as each person needed two doses to be vaccinated against the virus.
Pfizer, which also has an agreement with Israel, welcomed the first approval given for their vaccine worldwide.
"Giving approval is actually a goal we have set for ourselves since the first time we announced science would defeat the epidemic," said Pfizer CEO Albert Burla.
Share on Facebook
Share on WhatsApp
Share on general
Share on general
Share on Twitter
Share on Email
0 comments
